[Systemic lupus erythematosus: study of 48 patients with emphasis on renal involvement].
Boas
M de L
Mde L
Nakayama
E E
EE
Carvalho
M F
MF
Delfino Filho
J F
JF
Neiva
S L
SL
Habermann
F
F
Franco
R J
RJ
Soares
V A
VA
de Almeida
D B
DB
D000293:Adolescent; D000328:Adult; D002648:Child; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D008181:Lupus Nephritis / Q000097:blood / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies
D003520:Cyclophosphamide; D003404:Creatinine; D011241:Prednisone
Lúpus eritematoso sistêmico: estudo de 48 pacientes com ênfase no comprometimento renal.